Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis
Y. H. Kao(National Taiwan University Hospital), Ming‐Hong Tai(National Sun Yat-sen University), David Chao(National Sun Yat-sen University), Tsung‐Hui Hu(National Sun Yat-sen University), Shiao-Mei Kuo(National Sun Yat-sen University), Den-Chyang Wu(Kaohsiung Medical University), Shigeru Goto(Kaohsiung Chang Gung Memorial Hospital), Yu‐Chun Lin(National Tsing Hua University), Kuang‐Hung Cheng(National Sun Yat-sen University), Chao‐Long Chen(Kaohsiung Chang Gung Memorial Hospital), Yueh-Hua Chung(Memorial Hospital of South Bend), Hoi‐Hung Chan(Kaohsiung Veterans General Hospital), Cheuk‐Kwan Sun(E-Da Hospital), Yu‐Fan Cheng(Shanghai Medical College of Fudan University), Bruno Jawan(Kaohsiung Chang Gung Memorial Hospital)
Cited by 51
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Both p16 <sup>Ink4a</sup> and the p19 <sup>Arf</sup> -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse
|Proceedings of the National Academy of Sciences|2006|585
Hepatogastroenterology
|Hepatogastroenterology|2012|536